PERINATOLOGIYA I PEDIATRIYA.2014.2(58):13-15; doi 10.15574/PP.2014.58.13 

Modern aspects of prophylaxis and treatment of the fetus growth retardation syndrome. 
 

Маkarenko М. V.

Kiev Meternity Hospital №5 
 

Purpose: to develop the aspects of prophylaxis of the fetus growth retardation syndrome among pregnant women with the fetoplacental insufficiency. 
 

Patients and methods: There were studied the pregnancy passing, birth and perinatal outcomes among 220 patients with the signs of placental insufficiency (according to the ultrasonic diagnostics), without the hemodynamic instability in the system «mother-placenta-fetus», and the risk of the fetal growth retardation development syndrome. The first group consist of 120 patients who got the medical complex directed on the placental dysfunction therapy and the fetus growth retardation prophylaxis, the second one consist of the 100 pregnant women with the the risk of the above syndrome who got any prevention treatment. According to this methodic on 14–16 pregnancy week it was appointed the micronized progesterone 200 mg twice a day intravaginal; the combined polyvitamin complex of micro- and macro-elements; potassium iodide 200 mg per day; the complex of the polyunsaturated omega-3 fatty acids family; the dry water extract of fresh artichoke leaves 2 tablets 3 times a day. 
 

Results: the first group (main) newborns had no severe fetal hypoxia as the comparison group got 13% index. First group children 90 (90%) were born in a satisfactory condition (Apgar scale 8–10); in a state of mild asphyxia — 8 (8%); moderate severity rank – 2 (2%); severe rank – 0. The second group of children (the comparison) who were born in an asphyxia state mostly predominated: light rate — 10 (10%); middle — 9 (9%); hard — 12 (12%). 
 

Conclusion: the prevention and treatment conducting of the very syndrome among the patients with the risk group is a reserve for reducing low birth among the children with a low body weight and it improves the medical care for pregnant women and newborns. 
 

Key words: SFRG, prevention, treatment. 
 

REFERENCES

1. Акушерство и гинекология: клинические рекомендации. Под ред. ГМ. 2008. Савельевой. М. Вып 3: 506.

2. Акушерство. Нац. рук-во. Под ред. Айламазяна ЭК, Кулакова ВИ, Радзинского ВЕ, Савельевой ГМ. 2007. М, ГЭОТАР-Медиа: 1200. (Серия «Национальные руководства»).

3. Бушуева ЭВ, Герасимова ЛИ, Денисова ТГ. 2010. Мониторинг физического развития детей раннего возраста в зависимости от массы тела при рождении. Общественное здоровье и здравоохранение. Казань 1: 40—43.

4. Крымшокалова ЗС и др. 2008. К вопросу о курабельности синдрома задержки роста плода. Рос вестник акушера-гинеколога. 8;3: 59—61.

5. Cидорова ТН и др. 2010. Мониторинг факторов риска рождения детей с синдромом задержки внутриутробного развития. Общественное здоровье и здравоохранение Казань 2: 73—74.

6. Оразмурадов АА, Апресян СВ. 2009. Плацентарная недостаточность: реалии и перспективы. Информационное письмо. М: 32.

7. Педиатрия. Нац рук-во. Под ред Баранова АА. 2009. М, ГЭОТАР-Медиа: 1024.

8. Радзинский ВЕ, Ордиянц ИМ, Коршунова ЛП. 2007. Перспективные пути патогенетически обоснованной профилактики и лечения фетоплацентарной недостаточности. РМЖ 4: 325—328.